Stay updated on Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial

Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide notice announces changes to NIH terminology and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T14:40:25.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:28:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:31:56.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page shows a 403 Forbidden error, indicating restricted access to the study record.
    Difference
    0.2%
    Check dated 2026-09-26T17:07:20.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record content, effectively blocking access to the study details and linked documents on this page.
    Difference
    18%
    Check dated 2026-09-19T18:43:01.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now shows a newer revision tag (v3.6.6) replacing the previous v3.6.5, indicating a minor site update. The update does not alter the study details, eligibility criteria, or outcome measures.
    Difference
    0.0%
    Check dated 2026-08-29T21:44:21.000Z thumbnail image

Stay in the know with updates to Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.